Eliem Therapeutics Gross Margin 2021-2024 | CLYM
Current and historical gross margin for Eliem Therapeutics (CLYM) over the last 10 years. The current gross profit margin for Eliem Therapeutics as of June 30, 2024 is %.
Eliem Therapeutics Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|